Argent Biopharma Ltd (RGT.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2015 | 06-2014 | 06-2013 | 06-2012 | 06-2011 | |
| Cash Flows From Operating Activities | |||||
| Operating Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -8 | N/A | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -5 |
| Other Investing Activity | -316 | -508 | -2,215 | 0 | 0 |
| Investing Cash Flow | $-316 | $-508 | $-2,223 | $N/A | $-5 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 131 | N/A | 85 |
| Debt Repayment | N/A | N/A | N/A | -38 | -5 |
| Common Stock Issued | 797 | 1,574 | 2,592 | 250 | 1,362 |
| Common Stock Repurchased | -21 | -158 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | -289 | -388 | -20 |
| Financing Cash Flow | $777 | $1,417 | $2,434 | $-176 | $1,422 |
| Exchange Rate Effect | -1 | -3 | -29 | N/A | N/A |
| Beginning Cash Position | 595 | 161 | 516 | 1,071 | 59 |
| End Cash Position | 437 | 595 | 161 | 516 | 1,071 |
| Net Cash Flow | $-158 | $436 | $-325 | $-555 | $1,058 |
| Free Cash Flow | |||||
| Capital Expenditure | -316 | -508 | -2,223 | N/A | -5 |
| Free Cash Flow | -316 | -508 | -2,223 | 0 | -5 |